Review
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 11690-11701
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11690
Table 1 Ubiquitin-specific proteases studied in breast cancer
USPs
Expression
Potential role in breast cancer
Signal pathway
USP1UpregulatedTumor promoterKPNA2, ERα signaling, Hippo signaling pathway, TGF-β signaling[20-23]
USP4UpregulatedTumor suppressorPDCD4, circBMPR2, PAK5-DNPEP pathway, Relaxin/TGF-β1/Smad2/MMP-9 signaling, TGF-β signaling[24-28]
USP7UpregulatedTumor promoterPHF8,DNA repair, Aurora-A kinase, ECT2[29-34]
USP9XUpregulatedTumor promoter, Tumor suppressorCEP131, Hippo Pathway, Notch signaling, Cyclin D1,Wnt signaling, TRAIL, YAP1[35,37,38,40,41,45,46]
USP11UpregulatedTumor promoterTGFβ signaling, DNA damage, XIAP[47-49]
USP14UpregulatedTumor promoterCyclinB1, Wnt/β-catenin and PI3K/AKT pathways, cell cycle[53,54]
USP15UpregulatedTumor promoterDNA repair, ERα signaling[65,66]
USP18UpregulatedTumor promoterAKT/Skp2 pathway[68]
USP20UpregulatedTumor promoterSNAI2[69]
USP22UpregulatedTumor promoterc-Myc, Hh pathway[57,58]
USP28UpregulatedTumor suppressorHIF-independent pathway, LSD1[71,72]
USP32UpregulatedTumor promoterUnknown[73]
USP33UpregulatedTumor suppressorSlit-Robo signaling[74]
USP37UpregulatedTumor promoterStemness, epithelial-mesenchymal transition[60]
USP39UpregulatedTumor promoterG0/G1-phase arrest, CHEK2[62,63]